Medical experts advise that people should get a vaccine for the bird flu when it becomes commercially available. One doctor ...

Moderna surged as investors turned eyed potential demand for a vaccine to protect against bird flu after the US reported its ...

We don’t have answers for all the deadly infectious diseases in the world, a fact made painfully clear Monday as Louisiana ...

The S&P 500 fell 1.1% on Tuesday, Jan. 7, as U.S. manufacturing data reinvigorated concerns about inflation and the interest ...

The company is one of a few drugmakers currently developing a vaccine for the illness, which is spreading rapidly through ...

A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.

Key Takeaways Moderna shares jumped more than 10% to lead S&P 500 gainers Tuesday, a day after the first bird-flu death was ...

The announcement follows just days after the US Centres for Disease Control confirmed its first death from the zoonotic ...

Moderna stock ( MRNA) fell over 9% on Wednesday, forfeiting most of its gains from Tuesday's session during a volatile week for the stock seen after the first reported bird flu death in the US, which ...

Jefferies sees Arbutus (ABUS) potentially benefitting from vaccines being developed by Moderna (MRNA) and Pfizer (PFE)/GSK ...

Bird flu has severely impacted poultry farms and cattle herds across 16 states, marking the worst outbreak of its kind.

Shares of Moderna (MRNA), one of a few drugmakers currently developing a vaccine for the H5N1 bird flu, were up nearly 10% in early trading ...